The financials
Solventum by the numbers
Solventum (SOLV) reported revenue of $2.21B in Q2 2026 (quarter ended June 30, 2026), up 2.2% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $92M (4.2% of revenue). For the full year FY2025, revenue was $8.32B (+0.9% year on year) and net income $1.56B. Its largest segment in 2026-Q2 was Med Surg at $537M, 42% of the disclosed total, just ahead of Dental Solutions at 31%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.21B | $2.16B | +2.2% |
| Gross profit | $1.29B | $1.18B | +9.4% |
| Operating income | $181M | $214M | −15% |
| Net income | $92M | $90M | +2.2% |
| Diluted EPS | $0.53 | $0.51 | +3.9% |
| Operating | Revenue | Share |
|---|---|---|
| Med Surg | $537M | 42% |
| Dental Solutions | $396M | 31% |
| Health Information Systems | $354M | 28% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q2 2026Total $1.29B (+7.9%)
Dental Solutions grew +17% year on yearPurification And Filtration -100% year on year
Segment Latestquarter on quarteryear on year
- Med Surg$537.0M$537.0MQoQ +8.0%year on year +15%+8.0%+15%
- Dental Solutions$396.0M$396.0MQoQ +12%year on year +17%+12%+17%
- Health Information Systems$354.0M$354.0MQoQ +3.5%year on year +4.4%+3.5%+4.4%
- Purification And Filtration$0.00$0.00QoQ -year on year -100%--100%
Medical Instruments & Supplies
Ranks #5 of 27 by Smart Score